100 Active Studies

Hidradenitis Suppurativa Clinical Trials

Find actively recruiting research studies for hidradenitis suppurativa. Connect with study sites near you and explore new treatment options.

100
Active Trials
331+
Locations
77,255
Participants Needed

Recruiting Studies

RecruitingNCT06534892

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 conse...

10 locations(Birmingham, Birmingham, Huntsville)
10,353 participants
GlaxoSmithKline
View Study Details
RecruitingNCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

This study will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascu...

10 locations(Dothan, Fairhope, Huntsville)
5,056 participants
Amgen
View Study Details
RecruitingNCT05774951

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk f...

10 locations(Birmingham, Dothan, Anchorage)
4,300 participants
AstraZeneca
View Study Details
RecruitingNCT06935370

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with c...

10 locations(Mobile, Montgomery, Beverly Hills)
4,200 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT06821061

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants i...

10 locations(Anaheim, Lake Forest, Riverside)
2,645 participants
BioNTech SE
View Study Details
RecruitingNCT06679140

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospital but who are at high risk for progressio...

10 locations(Little Rock, Bakersfield, Inglewood)
2,330 participants
Pfizer
View Study Details
RecruitingNCT06824194

Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneumococcal vaccine) compared to a licensed 20-valent ...

10 locations(Guntersville, Jonesboro, Concord)
2,320 participants
Sanofi
View Study Details
RecruitingNCT05436834

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

This study will evaluate the safety and immunogenicity of the mRNA-1273.214 vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concerns (VOCs) in participants aged 6 m...

10 locations(Bessemer, Banning, Montebello)
1,860 participants
ModernaTX, Inc.
View Study Details
RecruitingNCT06740630

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age

The purpose of this study is to assess the consistency of immune response to three different lots of GSK's investigational varicella vaccine (VNS Vaccine), and to compare the safety and immune respons...

5 locations(Tampa, Bingham Farms, McAllen)
1,840 participants
GlaxoSmithKline
View Study Details
RecruitingNCT05303636

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD) at the lumbar spine after 12 months (13 medication ...

10 locations(Phoenix, Denver, Coral Gables)
1,710 participants
Insud Pharma
View Study Details
RecruitingNCT06736041

Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether PCV21 vaccine (investigational pneumococcal conjugate vaccine) is safe and can help the body to develop g...

10 locations(Tucson, Fayetteville, Huntington Park)
1,630 participants
Sanofi Pasteur, a Sanofi Company
View Study Details
RecruitingNCT05889182

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), inguinal (groin) and anogenital (anal/genital) regions. This study will assess how s...

10 locations(Birmingham, Fountain Hills, Phoenix)
1,328 participants
AbbVie
View Study Details
RecruitingNCT06468228

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts, under ar...

10 locations(Birmingham, Phoenix, Tucson)
1,280 participants
AbbVie
View Study Details
RecruitingNCT06838000

Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents

The purpose of this study is to evaluate the safety and immunogenicity of PCV21 versus 20vPCV ( 20-valent pneumococcal conjugate vaccine, Prevnar 20) for catch-up vaccination in infants (7 to 11 MoA-M...

10 locations(Paramount, Doral, Hialeah)
1,252 participants
Sanofi Pasteur, a Sanofi Company
View Study Details
RecruitingNCT06061861

Kaiser Permanente Evaluating Nutritional Interventions in Food-Insecure High-Risk Adults Study

The goal of this randomized controlled trial is to compare the effect of receiving 6 months of monetary support for healthy food through a food delivery platform on change in glycosylated hemoglobin (...

2 locations(Pasadena, Pleasanton)
1,100 participants
Kaiser Permanente
View Study Details
RecruitingNCT04396574

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will la...

10 locations(Birmingham, Huntsville, Phoenix)
1,000 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05862272

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatm...

10 locations(Mobile, Chandler, Mesa)
1,000 participants
Sumitomo Pharma Switzerland GmbH
View Study Details
RecruitingNCT06212999

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to evaluate long-term safety and efficacy of povorcitinib in participants with moderate to severe hidradenitis suppurativa who completed the 54 weeks of study treatment wi...

10 locations(Phoenix, Scottsdale, Fort Smith)
960 participants
Incyte Corporation
View Study Details
RecruitingNCT06141486

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to 36 months ...

10 locations(Homewood, Phoenix, Scottsdale)
900 participants
Sanofi
View Study Details
RecruitingNCT06855160

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

This study aims to assess the immune response and safety of GSK's candidate chickenpox and marketed MMR vaccines when given to children 12 to 15 months of age via a muscle injection. It compares the G...

6 locations(Tucson, Huntington Park, Sherman Oaks)
900 participants
GlaxoSmithKline
View Study Details
RecruitingNCT06720038

A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants

The objective of the study is to evaluate the safety, tolerability, and immunogenicity of 4 injections of VAX-31 (at 4 dose levels) compared to PCV20 in infants at 2, 4, 6, and 12-15 months of age, in...

10 locations(Jonesboro, Gardena, Los Angeles)
900 participants
Vaxcyte, Inc.
View Study Details
RecruitingNCT07076199

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

This study compares insulin icodec, an insulin taken once a week to insulin glargine, an insulin taken once a day. The study medicine will be investigated in participants with type 1 diabetes. The stu...

10 locations(Cullman, Concord, Escondido)
877 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT06822790

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

This is an open-label study to be conducted in adults with hypertriglyceridemia (HTG) and severe hypertriglyceridemia (SHTG). Each participant must have completed all required visits per protocol in t...

7 locations(Miami Lakes, Jefferson City, Omaha)
840 participants
Arrowhead Pharmaceuticals
View Study Details
RecruitingNCT05917522

Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

800 adult first time kidney transplant recipients will be enrolled in the Observational Study and followed to evaluate their Human Leukocyte Antigen (HLA)-DR/DQ molecular mismatch (mMM) score as a ris...

10 locations(Birmingham, Los Angeles, Los Angeles)
800 participants
National Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
RecruitingNCT05232916

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

This is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects who are at high risk f...

10 locations(Tucson, Fullerton, La Jolla)
750 participants
Greenwich LifeSciences, Inc.
View Study Details
RecruitingNCT05914805

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)

The purpose of the study is to see if Clascoterone can help people with male pattern hair loss to recovery and see if the treatment is effective and safe and how well the drug is tolerated by subjects...

10 locations(Scottsdale, Hollywood, Atlanta)
726 participants
Cassiopea SpA
View Study Details
RecruitingNCT05910450

A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

The purpose of the study is to see if Clascoterone can help people with male pattern hair loss to recovery and see if the treatment is effective and safe and how well the drug is tolerated by subjects...

10 locations(North Little Rock, San Diego, Jacksonville)
726 participants
Cassiopea SpA
View Study Details
RecruitingNCT05099770

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-bio...

10 locations(Tucson, Beverly Hills, Glendora)
685 participants
Prokidney
View Study Details
RecruitingNCT06091202

Tele-Collaborative Outreach to Rural Patients With Chronic Pain

This is a randomized controlled trial comparing the effectiveness of a remotely delivered collaborative care intervention for chronic pain versus a minimally enhanced control group. The specific aims ...

4 locations(Minneapolis, Portland, Nashville)
608 participants
Oregon Health and Science University
View Study Details
RecruitingNCT06972472

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

The main purpose of this study is to see how orforglipron, compared with placebo, helps improve glycemic control in participants with obesity or with overweight and type 2 diabetes. This trial is part...

10 locations(Tucson, San Ramon, Santa Ana)
600 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06972459

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity

The main purpose of this study is to see how orforglipron, compared with placebo, helps reduce body weight in participants with obesity or with overweight and at least one other related health conditi...

10 locations(Tucson, San Ramon, Santa Ana)
600 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06824181

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to measure whether the investigational pneumococcal conjugate vaccine PCV21 is safe and can help the body to develop germ-fi...

10 locations(Hollywood, Miami, Sioux City)
580 participants
Sanofi
View Study Details
RecruitingNCT06840392

Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis sup...

10 locations(Birmingham, Gilbert, Scottsdale)
555 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT06799000

A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa

The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis sup...

10 locations(Fort Smith, North Little Rock, Anaheim)
555 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT07146022

Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)

This study will evaluate the safety and efficacy of VDPHL01 in female subjects with Androgenetic Alopecia (AGA). AGA is a genetic disorder caused by an excessive (too much) hair follicle response to ...

10 locations(Birmingham, Birmingham, Phoenix)
552 participants
Veradermics, Inc.
View Study Details
RecruitingNCT06338995

A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with chronic rhinosinusitis and nasal polyps treated with intranasal corticosteroids. The st...

10 locations(Birmingham, Birmingham, Arcadia)
510 participants
Eli Lilly and Company
View Study Details
RecruitingNCT04442022

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or Without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma

The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive hematopoetic stem ce...

10 locations(Chandler, Tucson, Cerritos)
501 participants
Karyopharm Therapeutics Inc
View Study Details
RecruitingNCT07117487

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

The purpose of this study is to evaluate safety, tolerability and immunogenicity of mRNA-1345 in participants who have been previously vaccinated with either Arexvy or Abrysvo at least 12 months prior...

10 locations(Denver, Hialeah, Savannah)
500 participants
ModernaTX, Inc.
View Study Details
RecruitingNCT06571383

STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss

The study is testing how well semaglutide can help adolescents with excess body weight to lose weight and to maintain weight loss. All participants in the study will receive semaglutide as a weekly in...

10 locations(Escondido, Orlando, Tallahassee)
500 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT06972264

Safety and Efficacy of VDPHL01 in Males With AGA

This study will evaluate the safety and efficacy of VDPHL01 in male subjects with Androgenetic Alopecia (AGA). AGA (or male pattern baldness) is a genetic disorder caused by an excessive (too much) h...

10 locations(Birmingham, Birmingham, Phoenix)
480 participants
Veradermics, Inc.
View Study Details
RecruitingNCT06962280

A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last abo...

10 locations(Bonita, Escondido, Newport Beach)
465 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06201676

Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients

The goal of this randomized clinical trial is to learn if the use of a low-dose nonsteroidal anti-inflammatory drug (NSAID), ketorolac, reduces the rate of chronic opioid use in orthopaedic polytrauma...

2 locations(Boston, Nashville)
458 participants
Massachusetts General Hospital
View Study Details
RecruitingNCT06339008

A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)

The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to...

10 locations(Huntington Beach, Inglewood, Laguna Niguel)
450 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06958211

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS2)

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa....

10 locations(Birmingham, Birmingham, Montgomery)
450 participants
Incyte Corporation
View Study Details
RecruitingNCT05806164

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

The goal of this clinical trial is to compare treatment outcomes between an oral medication (beta agonist) versus onabotulinumtoxinA injections in women with urgency urinary incontinence (UUI). Parti...

5 locations(Birmingham, San Diego, Washington D.C.)
432 participants
Women and Infants Hospital of Rhode Island
View Study Details
RecruitingNCT06894511

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC

The purpose of this study is to assess whether the combination of AAA617 (administered for 6 cycles at a dose of 7.4 GBq (200 mCi) +/- 10%) and ARPI improves radiographic progression-free survival (rP...

4 locations(Casa Grande, Fayetteville, Newport Beach)
420 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT06295731

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody INBRX-106 combined with the anti-PD-1 antibody pembrolizumab versus pe...

10 locations(Duarte, Los Angeles, Sacramento)
410 participants
Inhibrx Biosciences, Inc
View Study Details
RecruitingNCT06351631

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

The primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include participants who are safely tolerating bome...

10 locations(Ann Arbor, Durham, Columbus)
400 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06075953

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

The goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an early stage of breast cancer, can be an effe...

10 locations(Berkeley, San Francisco, Walnut Creek)
400 participants
QuantumLeap Healthcare Collaborative
View Study Details
RecruitingNCT06959225

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa....

10 locations(Phoenix, Scottsdale, Tempe)
400 participants
Incyte Corporation
View Study Details
RecruitingNCT06581328

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this stud...

10 locations(Mobile, Colorado Springs, Colorado Springs)
400 participants
Takeda
View Study Details
RecruitingNCT06857955

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients with mild to moderate hy...

10 locations(Andalusia, Tucson, Garden Grove)
380 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT06396247

Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance

In this study, we will randomly assign 360 older adults to 12 months of 5 minutes per day of functional resistance training or to a delayed treatment control condition, and measure the impact of the t...

2 locations(Hershey, Pittsburgh)
360 participants
Milton S. Hershey Medical Center
View Study Details
RecruitingNCT05559359

A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18 years of age with moderate-to-severe atopic dermat...

10 locations(Birmingham, Phoenix, North Little Rock)
360 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06958328

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

This phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have received an initial ...

10 locations(Gilbert, Peoria, Phoenix)
356 participants
NRG Oncology
View Study Details
RecruitingNCT06507618

Pre-Operative Window of ET to Inform RT Decisions (POWER II)

This is a Phase III, multisite exploratory study for women ≥ 65 years of age with early stage estrogen receptor positive (ER+) breast cancer. These individuals will be treated randomly assigned to one...

3 locations(Charlottesville, Fairfax, Richmond)
354 participants
University of Virginia
View Study Details
RecruitingNCT05976243

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension (OLE). The purpose of the core period (52 weeks o...

10 locations(Birmingham, Little Rock, Bakersfield)
348 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT05995964

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic dermatitis (AD). AD is a long- lasting itchy red rash,...

10 locations(Birmingham, Peoria, Phoenix)
340 participants
Pfizer
View Study Details
RecruitingNCT06280950

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

This is a study to determine the safety, efficacy, and tolerability of taking away the anti-rejection medicine, tacrolimus, in liver transplant recipients in conjunction with everolimus monotherapy to...

8 locations(Phoenix, San Francisco, Chicago)
340 participants
National Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
RecruitingNCT06297603

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and renal impairment, with inadequate glycemic control on ...

10 locations(Huntsville, Sun City West, Apple Valley)
320 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06719141

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)

This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and...

10 locations(Little Rock, Palo Alto, San Francisco)
320 participants
Longboard Pharmaceuticals
View Study Details
RecruitingNCT05615844

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participant...

10 locations(Chandler, Los Angeles, Los Angeles)
312 participants
University of Maryland, Baltimore
View Study Details
RecruitingNCT07047716

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

The goal of this clinical study is to learn more about the study drug lenacapavir (LEN), safety, tolerability, and pharmacokinetics (how LEN is absorbed, modified, distributed, and removed from the bo...

8 locations(Los Angeles, Los Angeles, Ft. Pierce)
300 participants
Gilead Sciences
View Study Details
RecruitingNCT06325566

Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexle...

10 locations(Phoenix, Chula Vista, Concord)
300 participants
Mesoblast, Ltd.
View Study Details
RecruitingNCT05857930

A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing

This study will assess the efficacy and safety of daily OM-85 treatment compared to placebo in children aged 6 months to 5 years with recurrent wheezing...

10 locations(Phoenix, Phoenix, Tucson)
288 participants
OM Pharma SA
View Study Details
RecruitingNCT05150704

MYTHS - MYocarditis THerapy With Steroids

This is a phase III, multi-center international, single blind randomized controlled trial to test the efficacy of pulsed intravenous (IV) methylprednisolone versus standard therapy on top of maximal s...

10 locations(San Diego, Houston, Charlottesville)
288 participants
Niguarda Hospital
View Study Details
RecruitingNCT06873581

Pivotal Study of Voro Urologic Scaffold

The objective of this study is to compare safety and effectiveness of the Voro Urologic Scaffold in adult men undergoing robotic assisted radical prostatectomy as compared to control arm. The study i...

10 locations(Tampa, Indianapolis, Baltimore)
266 participants
Levee Medical, Inc.
View Study Details
RecruitingNCT06977581

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition t...

10 locations(Mobile, Lancaster, San Jose)
252 participants
Pfizer
View Study Details
RecruitingNCT05180773

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on my...

10 locations(Birmingham, Tucson, La Jolla)
250 participants
Dennis M. McNamara, MD, MS
View Study Details
RecruitingNCT05695027

Nicotinamide and Pyruvate for Open Angle Glaucoma: A Randomized Clinical Study

The objective of this study is to determine if a combination of oral nicotinamide and pyruvate (N\&P) can maintain eye health as compared to placebo while standard-of-care intraocular pressure-lowerin...

3 locations(Palo Alto, New York, New York)
250 participants
Columbia University
View Study Details
RecruitingNCT06545955

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a complete response (CR) at 3...

10 locations(Los Angeles, Los Angeles, Orange)
250 participants
Ferring Pharmaceuticals
View Study Details
RecruitingNCT05556824

Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD

This study will be conducted as a multi-center, randomized, double-blind, placebo-controlled trial to evaluate the effect of MHS-1031 on heartburn-free days in subjects with GERD-related heartburn sym...

10 locations(Phoenix, Lake City, Miami)
247 participants
Microbiome Health Sciences
View Study Details
RecruitingNCT06897475

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

The purpose of this study is to measure the change in hemoglobin A1c (HbA1c) with LY3457263 compared with placebo in participants with type 2 diabetes who are not at HbA1c goal when treated with a sta...

10 locations(Phoenix, Santa Ana, Ocala)
240 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06615557

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)

This U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve...

10 locations(Little Rock, Bellflower, Orange)
236 participants
VistaGen Therapeutics, Inc.
View Study Details
RecruitingNCT06358651

Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-3)

This U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve...

10 locations(Phoenix, Fayetteville, Little Rock)
236 participants
VistaGen Therapeutics, Inc.
View Study Details
RecruitingNCT05438212

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

This phase III trial compares the usual treatment of surgery after stereotactic radiosurgery (SRS) to receiving SRS before surgery in treating patients with cancer that has spread to the brain (brain ...

10 locations(Phoenix, Tucson, Tucson)
236 participants
NRG Oncology
View Study Details
RecruitingNCT06603077

A Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients With Moderate to Severe Hidradenitis Suppurativa

The main purpose of this study is to evaluate the efficacy and safety of AVTX-009 compared with placebo in patients with moderate to severe Hidradenitis Suppurativa (HS)....

10 locations(Scottsdale, Tucson, Northridge)
222 participants
Avalo Therapeutics, Inc.
View Study Details
RecruitingNCT06847191

NE3107 in Adults With Neurological Symptoms of Long COVID

Long COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in ...

10 locations(San Francisco, Aurora, Jacksonville)
208 participants
BioVie Inc.
View Study Details
RecruitingNCT06254950

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

The main aim of this study is to learn if TAK-279 reduces bowel inflammation and symptoms compared to placebo. Another aim is to compare any medical problems that participants have when they take TAK-...

10 locations(Los Angeles, Murrieta, Orange)
207 participants
Takeda
View Study Details
RecruitingNCT06685835

A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)

The primary purpose of the study is evaluate the effect of brensocatib compared with placebo....

10 locations(Phoenix, Sacramento, Coral Gables)
204 participants
Insmed Incorporated
View Study Details
RecruitingNCT06220669

A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis

The main purpose of this study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will last about 9 months wit...

10 locations(Coral Springs, Fort Myers, Fort Myers)
200 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06864026

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe PsA and obesity or overw...

10 locations(Avondale, Chandler, Flagstaff)
200 participants
Eli Lilly and Company
View Study Details
RecruitingNCT03118986

RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic Chemotherapy

Chemotherapy-induced nausea and vomiting (CINV) are among the most bothersome symptoms during cancer treatment according to children and their parents. Most children receiving highly emetogenic chemot...

10 locations(San Francisco, Kansas City, New York)
200 participants
The Hospital for Sick Children
View Study Details
RecruitingNCT06857942

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity o...

10 locations(Phoenix, Fountain Valley, Fremont)
200 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06055608

Advancing Transplantation Outcomes in Children

This is a pediatric kidney transplant study comparing the safety and efficacy of an immunosuppressive regimen of belatacept and sirolimus to tacrolimus and Mycophenolate Mofetil (MMF). Two hundred par...

10 locations(Birmingham, Los Angeles, Los Angeles)
200 participants
National Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
RecruitingNCT04986423

ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer

This is an open-label, randomized, Phase 2b study of ZEN003694 in combination with enzalutamide vs. enzalutamide monotherapy in patients with mCRPC who have progressed on prior abiraterone by PCWG3 cr...

10 locations(Los Angeles, San Francisco, Whittier)
200 participants
Zenith Epigenetics
View Study Details
RecruitingNCT06228326

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

The Sponsor is developing KB707, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector that is designed to stimulate an anti-tumor immune response through the pro...

10 locations(Dothan, Scottsdale, Weston)
200 participants
Krystal Biotech, Inc.
View Study Details
RecruitingNCT07006792

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Pa...

10 locations(Birmingham, Litchfield Park, Phoenix)
200 participants
Eli Lilly and Company
View Study Details
RecruitingNCT04794530

The COCOA-PAD II Trial

Among people with peripheral artery disease (PAD) age 55 and older, the investigators will test the hypothesis that PAD participants randomized to cocoa flavanols will have greater improvement or less...

3 locations(Chicago, Chicago, Minneapolis)
190 participants
Northwestern University
View Study Details
RecruitingNCT06993610

Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense

The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, follow...

10 locations(Phoenix, Irvine, Los Angeles)
180 participants
Zura Bio Inc
View Study Details
RecruitingNCT07055516

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participan...

10 locations(Mesa, Los Angeles, Cooper City)
162 participants
NodThera Limited
View Study Details
RecruitingNCT06660394

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

This (DEEp SEA Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and a...

10 locations(Little Rock, Palo Alto, San Francisco)
160 participants
Longboard Pharmaceuticals
View Study Details
RecruitingNCT04047628

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell Transplantation (AHSCT...

10 locations(Palo Alto, Aurora, Evanston)
156 participants
National Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
RecruitingNCT05351294

Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet

To determine if the experimental approach of early radiation oncology involvement alongside standard oncologic care will result in higher HRQL at 6 months compared to the control arm receiving standar...

6 locations(Jersey City, New Brunswick, New Brunswick)
156 participants
Rutgers, The State University of New Jersey
View Study Details
RecruitingNCT06991556

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

This Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone compared with an androgen...

10 locations(Omaha, Myrtle Beach, Nashville)
150 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT06910358

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

The goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to answer are: * Whether bitopertin incre...

10 locations(Huntington Beach, San Francisco, Miami)
150 participants
Disc Medicine, Inc
View Study Details
RecruitingNCT05908084

To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis

The goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections between the ATEV and AVF groups over 12 months ...

10 locations(Scottsdale, El Centro, La Jolla)
150 participants
Humacyte, Inc.
View Study Details
RecruitingNCT06956235

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

This is a phase 2b randomized, double-blind, placebo-controlled study of the safety and efficacy of tulisokibart in participants with moderate to severe hidradenitis suppurativa. The primary hypothesi...

10 locations(Birmingham, Phoenix, Rogers)
147 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06517758

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 75 Years With gMG.

The study is a randomized, double-blind, placebo-controlled, multicenter, Phase III study, to evaluate efficacy, safety and tolerability of iptacopan in patients with AChR+ gMG who are on stable SOC t...

10 locations(Scottsdale, Fullerton, Pasadena)
146 participants
Novartis Pharmaceuticals
View Study Details
RecruitingNCT06480760

Effects of Carnosine In Patients With Peripheral Arterial Disease Patients

The purpose of this study is to determine whether carnosine (a food ingredient found in chicken and red meat) supplementation (2 g) for 6 months in participants with non-claudication and claudication ...

3 locations(Louisville, Louisville, Louisville)
144 participants
Shahid Baba
View Study Details

Frequently Asked Questions

What clinical trials are available for Hidradenitis Suppurativa?

There are currently 100 actively recruiting clinical trials for hidradenitis suppurativa. These studies are testing new treatments, therapies, and interventions at research sites across 331 cities.

How do I join a Hidradenitis Suppurativa clinical trial?

To join a hidradenitis suppurativa clinical trial: 1) Browse the available studies above, 2) Click on a study that interests you, 3) Complete the eligibility form, and 4) A study coordinator will contact you.

Are clinical trials free for patients?

Yes, clinical trial participation is free. In most studies, the treatment, medical tests, and doctor visits related to the trial are provided at no cost. Some studies may also compensate for time and travel.

Can I leave a clinical trial if I change my mind?

Yes, participation in any clinical trial is completely voluntary. You can withdraw at any time, for any reason, without affecting your regular medical care.